Tetrahydroisoquinolines as subtype selective estrogen agonists/antagonists
摘要:
Two series of 6-hydroxy and 7-hydroxy tetrahydroisoquinolines were prepared. Evaluating a range of C-1, C-4, and N-substituents led to the discovery of ER alpha and ER beta selective analogs. (C) 2004 Elsevier Ltd. All rights reserved.
Tetrahydroisoquinolines as subtype selective estrogen agonists/antagonists
摘要:
Two series of 6-hydroxy and 7-hydroxy tetrahydroisoquinolines were prepared. Evaluating a range of C-1, C-4, and N-substituents led to the discovery of ER alpha and ER beta selective analogs. (C) 2004 Elsevier Ltd. All rights reserved.
Tetrahydroisoquinoline compounds as estrogen agonists/antagonists
申请人:——
公开号:US20010039285A1
公开(公告)日:2001-11-08
This invention relates to compounds useful for treating or preventing obesity, breast cancer, osteoporosis, endometriosis, cardiovascular disease, prostatic disease, and the like, and to pharmaceutical composition, methods, and kits comprising such compounds.
Visible light as a sole requirement for alkylation of α-C(sp<sup>3</sup>)–H of <i>N</i>-aryltetrahydroisoquinolines with alkylboronic acids
作者:Feihu Cong、Wenjing Zhang、Gan Zhang、Jie Liu、Yicheng Zhang、Chao Zhou、Lei Wang
DOI:10.1039/d3ob01154b
日期:——
developed under visible-light irradiation in the absence of additional photocatalyst. The reaction proceeded well, tolerating a variety of functional groups, and featured low-cost and mild reaction conditions. A preliminary mechanistic study indicated that an electron donor–acceptor (EDA) complex between an electron-rich N-aryltetrahydroisoquinoline and an electron-poor alkylboronic acid was involved